Log In
Print
BCIQ
Print
Print this Print this
 

CRLX101 (formerly IT-101)

  Manage Alerts
Collapse Summary General Information
Company Calando Pharmaceuticals Inc.
DescriptionDual inhibitor of topoisomerase I (TOP1) and hypoxia-inducible factor 1 alpha (HIF1A; HIF1-alpha)
Molecular Target Topoisomerase I (TOP1) ; Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today